Roberto Polakiewicz

Chief Scientific Officer at Cell Signaling Technology

Roby drives research, product, and technology innovation, facilitating the creation of the most valuable products, technologies, and intellectual property at CST. Roby has driven the creation and implementation of novel antibody technology platforms that have been critical to the success of the organization. He previously served as Director of Research and Vice President for research at CST.

Before joining CST in 1999, he was a staff scientist at the biotechnology company New England Biolabs.

Roby received a B.S. in chemistry and Ph.D. in molecular biology from Hebrew University of Jerusalem, and he has completed postdoctoral studies at the Whitehead Institute for Biomedical Research at M.I.T. He has published approximately 65 peer-reviewed scientific articles and is a named inventor on numerous patents and patent applications.

Timeline

  • Chief Scientific Officer

    Current role

View in org chart